Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Yesterday, Nov. 14, 2013, 154 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $292.50 to $467,462,888.00.
Highlighted Stocks Traded by Insiders:
VistaPrint (VPRT) - FREE Research Report Page Louis who is Director at VistaPrint sold 12,100 shares at $54.91 on Nov. 14, 2013. Following this transaction, the Director owned 94,338 shares meaning that the stake was reduced by 11.37% with the 12,100 share transaction.
The shares most recently traded at $55.00, up $0.09, or 0.16% since the insider transaction. Historical insider transactions for VistaPrint go as follows:
- 4-Week # shares sold: 9,064
- 12-Week # shares sold: 15,592
- 24-Week # shares sold: 57,326
The average volume for VistaPrint has been 196,200 shares per day over the past 30 days. VistaPrint has a market cap of $1.8 billion and is part of the services sector and diversified services industry. Shares are up 68.75% year to date as of the close of trading on Thursday.
Vistaprint N.V. operates as an online provider of coordinated portfolios of marketing products and services to micro businesses worldwide. The company has a P/E ratio of 58.4. Currently there is 1 analyst that rates VistaPrint a buy, 2 analysts rate it a sell, and 6 rate it a hold.
Exclusive Offer: Get the latest Stock Analysis on VPRT - FREE TheStreet Quant Ratings rates VistaPrint as a
hold. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and weak operating cash flow. Get the full
VistaPrint Ratings Report from
TheStreet Quant Ratings now.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
